Schettler T, Aufm' Kolk B, Atkinson M J, Radeke H, Enters C, Hesch R D
Acta Endocrinol (Copenh). 1984 Sep;107(1):60-9. doi: 10.1530/acta.0.1070060.
A combination of high-performance-liquid-chromatography (HPLC), sensitive radioimmunoassays and a homologous in vitro bioassay was used to characterise human parathyroid hormone (hPTH)-peptides in human parathyroid adenoma and plasma. Chromatography of several synthetic hPTH-peptides allows the calibration of the HPLC column. On the basis of sequence hydrophobicity the elution position of peptides can be predicted. A model for the determination of the minimal peptide sequence of each peptide has been developed which based on immunological and physico-chemical properties allows the characterisation of unknown hPTH-peptides. Using this technique the heterogeneity of circulating hPTH-peptides in human plasma has been examined. Plasma extracts from healthy individuals, osteoporotic, hyperparathyroid and pseudo-hyperparathyroid patients were investigated. A uniform pattern in the heterogeneity of hPTH-peptides was detected. Using parathyroid adenoma as reference disease specific changes were characterised.
采用高效液相色谱(HPLC)、灵敏的放射免疫测定法和同源体外生物测定法相结合的方法,对人甲状旁腺腺瘤和血浆中的人甲状旁腺激素(hPTH)肽进行表征。几种合成hPTH肽的色谱分析可用于校准HPLC柱。根据序列疏水性可以预测肽的洗脱位置。已开发出一种确定每种肽最小肽序列的模型,该模型基于免疫和物理化学性质可对未知的hPTH肽进行表征。利用该技术检测了人血浆中循环hPTH肽的异质性。对健康个体、骨质疏松症患者、甲状旁腺功能亢进患者和假性甲状旁腺功能亢进患者的血浆提取物进行了研究。检测到hPTH肽异质性的统一模式。以甲状旁腺腺瘤为参照,对疾病特异性变化进行了表征。